Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart disease detective: 1,000-Person study hunts for hidden genetic triggers of sudden cardiac death

NCT ID NCT03049254

First seen May 05, 2026 · Last updated Jun 23, 2026 · Updated 7 times

Summary

This study is looking for new genes and blood markers linked to arrhythmogenic cardiomyopathy (AVC), a genetic heart condition that can lead to heart failure and sudden cardiac arrest. Researchers will enroll 1,000 people, including patients with AVC or unexplained cardiac arrest, and their blood relatives. By collecting medical data, images, and samples, they hope to better understand how the disease starts and progresses, which could improve diagnosis and screening for at-risk families.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Royal Papworth Hospital NHS Foundation Trust

    RECRUITING

    Papworth Everard, Cambridge, CB23 3RE, United Kingdom

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better genetic tests and early detection methods for arrhythmogenic cardiomyopathy, potentially preventing sudden cardiac death in at-risk families.

What could go wrong

This is an observational study, not a treatment trial. It may not directly benefit participants, and findings may take years to translate into clinical practice.

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac arrhythmogenic right ventricular cardiomyopathy cardiomyopathy Cardiovascular Abnormalities cardiovascular disorder Death, Sudden, Cardiac familial dilated cardiomyopathy heart disorder myocarditis sarcoidosis ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.